5fod: Difference between revisions

From Proteopedia
Jump to navigationJump to search
← Older edit
OCA (talk | contribs)
Bots, Bureaucrats, journal, Administrators
3,330,058 edits
No edit summary
OCA (talk | contribs)
Bots, Bureaucrats, journal, Administrators
3,330,058 edits
No edit summary
 
(4 intermediate revisions by the same user not shown)
Line 1: Line 1:


==Crystal structure of the P.falciparum cytosolic leucyl-tRNA synthetase editing domain (space group P1) containing deletions of insertions 1 and 3==
==Crystal structure of the P.falciparum cytosolic leucyl-tRNA synthetase editing domain (space group P1) containing deletions of insertions 1 and 3==
<StructureSection load='5fod' size='340' side='right' caption='[[5fod]], [[Resolution|resolution]] 1.70&Aring;' scene=''>
<StructureSection load='5fod' size='340' side='right'caption='[[5fod]], [[Resolution|resolution]] 1.70&Aring;' scene=''>
== Structural highlights ==
== Structural highlights ==
<table><tr><td colspan='2'>[[5fod]] is a 2 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5FOD OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5FOD FirstGlance]. <br>
<table><tr><td colspan='2'>[[5fod]] is a 2 chain structure with sequence from [https://en.wikipedia.org/wiki/Plasmodium_falciparum_3D7 Plasmodium falciparum 3D7]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5FOD OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=5FOD FirstGlance]. <br>
</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=EDO:1,2-ETHANEDIOL'>EDO</scene></td></tr>
</td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 1.7&#8491;</td></tr>
<tr id='related'><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat">[[5fo4|5fo4]], [[5foc|5foc]], [[5fof|5fof]], [[5fog|5fog]], [[5fol|5fol]], [[5fom|5fom]], [[5fon|5fon]]</td></tr>
<tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=EDO:1,2-ETHANEDIOL'>EDO</scene></td></tr>
<tr id='activity'><td class="sblockLbl"><b>Activity:</b></td><td class="sblockDat"><span class='plainlinks'>[http://en.wikipedia.org/wiki/Leucine--tRNA_ligase Leucine--tRNA ligase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=6.1.1.4 6.1.1.4] </span></td></tr>
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=5fod FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5fod OCA], [https://pdbe.org/5fod PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=5fod RCSB], [https://www.ebi.ac.uk/pdbsum/5fod PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=5fod ProSAT]</span></td></tr>
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5fod FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5fod OCA], [http://pdbe.org/5fod PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=5fod RCSB], [http://www.ebi.ac.uk/pdbsum/5fod PDBsum]</span></td></tr>
</table>
</table>
<div style="background-color:#fffaf0;">
== Function ==
== Publication Abstract from PubMed ==
[https://www.uniprot.org/uniprot/C6KT64_PLAF7 C6KT64_PLAF7]  
There is a need for new antimalarials, ideally with novel mechanisms of action. Benzoxaboroles have been shown to be active against bacteria, fungi, and trypanosomes. Therefore, we investigated the antimalarial activity and mechanism of action of 3-aminomethyl benzoxaboroles against Plasmodium falciparum Two 3-aminomethyl compounds, AN6426 and AN8432, demonstrated good potency against cultured multidrug-resistant (W2 strain) P. falciparum (IC50 310 nM and 490 nM, respectively) and efficacy against murine Plasmodium berghei infection when administered orally once daily for 4 days (ED90 7.4 and 16.2 mg/kg, respectively). To characterize mechanisms of action, we selected parasites with decreased drug sensitivity by culturing with step-wise increases in concentration of AN6426. Resistant clones were characterized by whole genome sequencing. Three generations of resistant parasites had polymorphisms in the predicted editing domain of the gene encoding a P. falciparum leucyl-tRNA synthetase (LeuRS; PF3D7_0622800) and in another gene (PF3D7_1218100), which encodes a protein of unknown function. Solution of the structure of the P. falciparum LeuRS editing domain suggested key roles for mutated residues in LeuRS editing. Short incubations with AN6426 and AN8432, unlike artemisinin, caused dose-dependent inhibition of [14C]leucine incorporation by cultured wild type, but not resistant parasites. The growth of resistant, but not wild type parasites was impaired in the presence of the unnatural amino acid norvaline, consistent with a loss of LeuRS editing activity in resistant parasites. In summary, the benzoxaboroles AN6426 and AN8432 offer effective antimalarial activity, and act, at least in part, against a novel target, the editing domain of P. falciparum LeuRS.


Anti-malarial benzoxaboroles target P. falciparum leucyl-tRNA synthetase.,Sonoiki E, Palencia A, Guo D, Ahyong V, Dong C, Li X, Hernandez VS, Zhang YK, Choi W, Gut J, Legac J, Cooper R, Alley MR, Freund YR, DeRisi J, Cusack S, Rosenthal PJ Antimicrob Agents Chemother. 2016 Jun 6. pii: AAC.00820-16. PMID:27270277<ref>PMID:27270277</ref>
==See Also==
 
*[[Aminoacyl tRNA synthetase 3D structures|Aminoacyl tRNA synthetase 3D structures]]
From MEDLINE&reg;/PubMed&reg;, a database of the U.S. National Library of Medicine.<br>
</div>
<div class="pdbe-citations 5fod" style="background-color:#fffaf0;"></div>
== References ==
<references/>
__TOC__
__TOC__
</StructureSection>
</StructureSection>
[[Category: Leucine--tRNA ligase]]
[[Category: Large Structures]]
[[Category: Ahyong, V]]
[[Category: Plasmodium falciparum 3D7]]
[[Category: Alley, M R.K]]
[[Category: Ahyong V]]
[[Category: Cooper, R]]
[[Category: Alley MRK]]
[[Category: Cusack, S]]
[[Category: Cooper R]]
[[Category: DeRisi, J]]
[[Category: Cusack S]]
[[Category: Dong, C]]
[[Category: DeRisi J]]
[[Category: Freund, Y R]]
[[Category: Dong C]]
[[Category: Guo, D]]
[[Category: Freund YR]]
[[Category: Gut, J]]
[[Category: Guo D]]
[[Category: Hernandez, V S]]
[[Category: Gut J]]
[[Category: Legac, J]]
[[Category: Hernandez VS]]
[[Category: Li, X]]
[[Category: Legac J]]
[[Category: Palencia, A]]
[[Category: Li X]]
[[Category: Rosenthal, P J]]
[[Category: Palencia A]]
[[Category: Sonoiki, E]]
[[Category: Rosenthal PJ]]
[[Category: Aminoacyl-trna synthetase]]
[[Category: Sonoiki E]]
[[Category: Ligase]]
[[Category: Novel boron inhibitors of leur]]
[[Category: P falciparum]]
[[Category: Protein biosynthesis]]

Latest revision as of 07:22, 1 May 2024

Crystal structure of the P.falciparum cytosolic leucyl-tRNA synthetase editing domain (space group P1) containing deletions of insertions 1 and 3

5fod, resolution 1.70Å

Drag the structure with the mouse to rotate

Proteopedia Page Contributors and Editors (what is this?)

OCA

Retrieved from "https://proteopedia.org/index.php?title=5fod&oldid=4137728"